Highlights
- Skin Elements continues to develop and commercialise its all-natural anti-microbial SE FormulaTM Biotechnology to enhance health and wellness of its customers naturally.
- Eco Nurture is a horticultural-specific plant-based bio stimulant product.
- Lab tests suggest that SuprCuvr is highly effective against viruses and bacteria.
- PapayaActivs is designed to help relieve the symptoms of skin conditions.
Skin Elements Limited (ASX: SKN) is engaged in the research and development of its proprietary all-natural anti-microbial SE FormulaTM Biotechnology. The ASX-listed company continues to develop and commercialise the technology to reach new markets across the globe and enhance health and wellness of its customers naturally.
Data source: company update
Eco Nurture Plant Bio Stimulant
SKN employed its biotechnology in Eco Nurture, which is a horticultural-specific plant-based bio stimulant product. The company highlights the product as an effective option to bactericides and fungicides (based on chemicals) used for protecting crops. The product brings in a massive opportunity in the growing agriscience market, says the company.
SuprCuvr
Skin Elements’ SuprCuvr has been developed from a 100% plant-based formula. As per independent laboratory tests, the TGA registered hospital-grade disinfectant has a 7-log reduction (99.99999%) effectiveness against bacteria and viruses. For its efficacy and nature-based formula, the company believes that the product holds potential to open a huge market opportunity as a chemical-free disinfectant.
The company has collaborated with Pacific Health Care Pty Ltd to analyse and understand the initial market position of the product.
Soléo Organics
Soléo Organics was the first application made using the SE Formula research and development program. It led to a significant progression in sun protection technology. For its quality, the product has been called as one of the world’s best sun protection formulas.
The firm has concluded development phase 2 for Soléo Organics. It is now initiating development phase 3.
PapayaActivs
Listed on the TGA’s Australian Register of Therapeutic Goods, this product has a high concentration of natural pawpaw extract and other active natural ingredients. It is designed to address symptoms of various skin conditions, as well as ease mild pain associated with muscles, and joints.
The company is studying the product under the development phase 2 with the aim to bring in formulation improvements and product range expansion.
SKN shares traded at AU$0.006 on 13 September 2023.